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Abstract
“Vaccine hesitancy” is a concept now frequently used in vaccination discourse. The
increased popularity of this concept in both academic and public health circles is challeng-
ing previously held perspectives that individual vaccination attitudes and behaviours are a
simple dichotomy of accept or reject. A consultation study was designed to assess the opin-
ions of experts and health professionals concerning the definition, scope, and causes of
vaccine hesitancy in Canada. We sent online surveys to two panels (1- vaccination experts
and 2- front-line vaccine providers). Two questionnaires were completed by each panel,
with data from the first questionnaire informing the development of questions for the second.
Our participants defined vaccine hesitancy as an attitude (doubts, concerns) as well as a
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behaviour (refusing some / many vaccines, delaying vaccination). Our findings also indicate
that both vaccine experts and front-line vaccine providers have the perception that vaccine
rates have been declining and consider vaccine hesitancy an important issue to address in
Canada. Diffusion of negative information online and lack of knowledge about vaccines
were identified as the key causes of vaccine hesitancy by the participants. A common
understanding of vaccine hesitancy among researchers, public health experts, policy-
makers and health care providers will better guide interventions that can more effectively
address vaccine hesitancy within Canada.
Introduction
Vaccination is widely considered to be one of the greatest achievements of public health [1].
Vaccination programs have contributed substantially to the decline in mortality and morbidity
of infectious diseases of major public health significance [2]. To be successful in reducing the
prevalence and incidence of vaccine-preventable diseases, vaccination programs rely on high
and sustained vaccine uptake [3–5]. In addition to direct protection for vaccinated individuals,
high vaccine coverage induces indirect protection for the overall community through the crea-
tion of herd immunity [6]. Childhood vaccination, moreover, is a specific public health priority
because children are particularly vulnerable to infectious diseases. Despite the relatively high
rate childhood vaccine coverage in Canada [7, 8], there are reasons to be concerned that vacci-
nation programs might be losing public confidence [9, 10]. Recent outbreaks of vaccine-pre-
ventable diseases in North America and Europe have been linked to under-vaccinated or non-
vaccinated communities, demonstrating the dramatic consequences of a decline in vaccine cov-
erage [11]. For instance, in 2015, a large measles outbreak started by an unvaccinated traveler
visiting Disneyland and spread to more than 20 US states, Mexico, and Canada [12].
“Vaccine hesitancy” is a concept now frequently used in vaccination discourse [13]. The
increased popularity of this concept in both academic and public health circles is challenging
previously held perspectives that individual vaccination attitudes and behaviours are a simple
dichotomy of accept or reject. Rather, vaccine hesitancy, is defined, as a continuum of vaccine
beliefs and associated behaviours ranging from complete refusal of all vaccines to complete vac-
cine acceptance [14, 15]. Vaccine-hesitant individuals are a heterogeneous group within this
continuum [16, 17]. They may refuse some vaccines, but agree to others; they may delay or
accept vaccines according to the recommended schedule but feel unsure about the “correct-
ness” of their decision relative to their child’s health [17–19]. The World Health Organization
(WHO) Strategic Advisory Group of Experts (SAGE) Working Group on Vaccine Hesitancy
defined vaccine hesitancy as a “delay in acceptance or refusal of vaccines despite availability of
vaccine services” [20]. According to SAGE, the scope of vaccine hesitancy includes instances
where “vaccine acceptance in a specific setting is lower than would be expected, given the avail-
ability of vaccination services. Vaccine hesitancy is complex and multi-dimensional; it varies
across time, place and vaccines” [20].
The WHO definition is focused on a binary behavioral outcome (e.g. vaccination or non
vaccination) in contrast to definitions usually used in the literature which also include attitudes
or beliefs (e.g. vaccination despite important doubts and concerns). Our research group identi-
fied a need for a common definition of vaccine hesitancy among researchers, public health
experts, policymakers and health care providers to advance our theoretical understanding of
the phenomenon and to better guide interventions that can more effectively address vaccine
hesitancy within Canada [21].
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In this context, the current study was designed to assess the opinions of researchers, public
health experts, policy decision-makers and healthcare providers concerning the definition,
scope, and causes of vaccine hesitancy in Canada.
Materials and Methods
Our study used two rounds of stakeholder questionnaires in an approach based on the Delphi
method, which is well suited for consensus-building [22, 23]. We sent online surveys (hosted
by SimpleSurvey) (Saint-Jean-sur-Richelieu, Québec (QC)) to two stakeholder groups (hereaf-
ter named panels): 1) health professionals, researchers, experts and policy-makers who were
members of the Canadian Association for Immunization Research and Evaluation (CAIRE)
and of the Canadian Immunization Research Network (CIRN); and 2) front-line vaccine pro-
viders (nurses and physicians). Eligible participants (members of the research team were
excluded) were invited to complete both questionnaires and two reminders were sent for the
first and the second questionnaire. The research ethics committee at the Centre de recherche du
CHU de Québec–Université Laval approved the study proposal.
Study participants and recruitment
The panels were constructed using a purposive sampling technique in a two-step procedure.
After obtaining the approval of the Canadian Immunization Research Network (CIRN) man-
agement committee and the Canadian Association for Immunization Research and Evaluation
(CAIRE) administrators, the principal investigator (ED) sent a study invitation to both CIRN
and CAIRE to distribute to all members inviting them to participate. CIRN[24] and CAIRE
[25] are non-mutually exclusive pan-Canadian networks including, respectively, approximately
100 and 300 members with diverse occupations (policymakers, experts/scientists/researchers,
health professionals) all involved in vaccination research, evaluation or decision-making, and
sometimes vaccine administration. Within the two rounds of data collection from CIRN and
CAIRE members (hereafter named “research networks members”), we identified a dearth of
responses from front-line vaccine providers. To remedy to this, team members identified 10 to
12 experienced vaccine providers within their 5 respective provinces to be invited to partici-
pate. The data collection process for this second panel was similar to the first. However, we
adapted the questionnaire to include a section regarding one-on-one counseling with vaccine-
hesitant patients (e.g. How do you counsel patients who have doubts and concerns regarding
vaccines? Are you reluctant to disclose information on risks of vaccination because of patients’
concerns and doubts?) and trust in research findings from different funding sources (e.g. gov-
ernment, industry).
Data collection
Data were collected via questionnaires from each panel of participants (detail available in S1
Table). Questionnaires were available in French and in English. The questionnaire was first
developed in English and then translated in French by the research team. A pre-test was made
(for the first questionnaire) with both English and French-speaking participants. The final ver-
sions were revised to make sure they were identical. Two questionnaires were completed by
each of the panels, ~ a month apart, with data from the first questionnaire informing the devel-
opment of questions for the second. All potential participants were invited to respond to both
questionnaires. The first questionnaire contained 15 open-ended questions to explore partici-
pants’ understanding of vaccine hesitancy and their views and perspectives about the causes
and consequences of vaccine hesitancy. The questionnaire was developed on the basis of a pre-
vious study of the determinants of vaccine hesitancy conducted with vaccination programs
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managers from 13 countries [26]. The second questionnaire contained 16 closed-ended ques-
tions which asked participants to indicate their level of agreement, scored using a 10-point
Likert scale, with statements about vaccine hesitancy that were derived from the first question-
naire. Participants were invited to provide additional comments in 3 open-text boxes in each
section of the questionnaire. Both questionnaires also contained 5 questions to assess profes-
sional characteristics of the participants (region of practice, role in immunization, specializa-
tion, numbers of years of work in immunization, vaccine administration).
The e-mailed invitation included a description of the consultation’s purpose, the duration
of the electronic survey (estimated to be less than 10 minutes), and a link to the online
questionnaire.
Data analysis
Content analysis was conducted on the open-ended responses. Conceptual categories were cre-
ated based upon the themes addressed in the questionnaire and were updated and revised until
no new properties, dimensions or relationships emerged. A senior research professional trained
in qualitative methods (DG) coded the data; a second researcher (ED) reviewed this work. Par-
ticipants’ definitions of vaccine hesitancy are illustrated in a word cloud that was developed
using N’Vivo 10 software (all words mentioned by participants were used except for short arti-
cles and pronouns).
Descriptive statistics were generated for all closed-ended responses. Wilcoxon test or Fish-
er’s exact test, as appropriate, were used to compare the characteristics of participants between
the first and second questionnaire rounds and validation analysis was conducted to identify
any statistically significant differences in participants’ responses according to the province of
practice. Responses on the 10-item Likert scale were divided into 3 subcategories (items 1 to 4
as “disagree”; 5 to 7 as “uncertain”; and items 8 to 10 as “agree”). Chi-squared or Fisher’s exact
tests, as appropriate, were used to compare these responses to the respondent characteristics.
In the second questionnaire, participants ranked the three main causes of vaccine hesitancy
from a list of 15 items taken from responses to the first questionnaire. A score was assigned to
the three items identified by each respondent, ranging from 1 (third most important cause) to
3 (first most important cause). A score of 0 was assigned to all items not selected among the
three most important causes of vaccine hesitancy by the respondent. Item scores were summed
to obtain a total raw score and means were calculated to have a final ranking of all causes. All
statistical analyses were performed using SAS version 9.2 (SAS Inc., Cary, N.C., USA). In all
instances a P-value<0.05 was considered statistically significant.
Results
A total of 52 research networks members and 98 front-line vaccine providers completed the
first questionnaire whereas 54 research networks members and 80 vaccine providers completed
the second questionnaire. Professional and demographic characteristics of the participants in
each round are presented in Table 1. Within each panel, there were no statistically significant
differences in participants’ characteristics between the first and the second questionnaires.
Participants’ definition of vaccine hesitancy
In the first round of data collection, participants were asked how they would define “vaccine
hesitancy”. The majority of participants defined vaccine hesitancy as a reluctance to receive
(recommended) vaccinations, mainly due to concerns about safety and efficacy of vaccines.
Others indicated that vaccine hesitancy was “having doubts” (some indicated unjustified
doubts) with regards to vaccines.
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In the second round, both stakeholder groups were invited to select their preferred defini-
tion among three choices provided: (a) the definition proposed by the WHO Strategic Advisory
Group of Experts Working Group on Vaccine Hesitancy [20]; (b) a definition derived from
highly cited studies on this topic [27, 28] and (c) a definition based on participants’ responses
on the first questionnaire (Table 2). The third definition was preferred by the majority of par-
ticipants in both panels.
Participants’ views regarding the impact of vaccine hesitancy on
vaccination programs in Canada
In the first round, 91% (n = 41) of research networks members reported that vaccine hesitancy
had an impact on vaccination programs in Canada. These participants reported that low vacci-
nation coverage and vaccination delays and refusals leading to vaccine-preventable diseases
outbreaks were the most common results, along with increased time needed to allay public
fears about vaccines.
Vaccine coverage is suboptimal, and vaccine providers waste time dealing with this that
they could be spending on more productive things. (Research networks member, Ontario)
Many research networks members also noted that the impact of hesitancy on vaccination pro-
grams is hard to quantify due to the lack of routinely collected vaccination data in many provinces.
Table 1. Demographics of participants in each questionnaire.*
Research Networks members Vaccine front-line providers
First
questionnaire
Second
questionnaire
First
questionnaire
Second
questionnaire
n (%) n (%) P-value n (%) n (%) P-value
(n = 52) (n = 54) (n = 98) (n = 80)
Region of practice
Atlantic (New Brunswick, Nova Scotia,
Newfoundland and Labrador, PEI)
3 (7) 9 (17) 7 (7) 6 (8)
Québec 5 (12) 12 (23) 11 (11) 12 (15)
Ontario 15 (37) 16 (31) 0.27 1 (1) 1 (1) 0.74
Prairies (Alberta, Manitoba, Saskatchewan) 13 (32) 12 (23) 8 (8) 3 (4)
British Columbia 5 (12) 3 (6) 71 (72) 57 (72)
Vaccination practices
I administer vaccines myself 13 (32) 21 (42) 0.39 94 (98) 79 (100) 0.50
Primary specialization
Epidemiologist 8 (19) 6 (11)
Nurse 2 (5) 3 (6) 87 (89) 72 (91)
Physician (family physician or paediatrician) 21 (51) 28 (54) 0.28 8 (8) 7 (9) 0.42
Program manager / administrator 5 (12) 2 (4)
Other 5 (12) 13 (25) 3 (3) 0
Number of years of work in immunization
< 10 years 14 (35) 20 (38) 31 (32) 29 (37)
10 to < 20 years 13 (32) 11 (21) 0.67 37 (38) 28 (35) 0.83
 20 years 12 (30) 19 (36) 29 (30) 22 (28)
Don't work in immunization 1 (2) 2 (4)
*Missing answers for 11 research networks members in the ﬁrst round and 1 vaccine provider in the second round
doi:10.1371/journal.pone.0156118.t001
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On-time immunization rates are almost certainly below what they were 10 years ago but
with no vaccine registry, how are we to know? Vaccine hesitancy requires much more time
from those who give vaccines to explain everything to parents. (Research networks member,
Prairies)
In the first round of data collection, 87% (n = 85) of front-line vaccine providers reported
that vaccine hesitancy resulted in increased time spent discussing vaccination issues with con-
cerned patients. Extra appointments were needed to accommodate patients who wanted to
spread out the vaccines over multiple visits.
More time needs to be taken with hesitant parents to provide information and education.
No shows, cancellations and extra appointments for altered vaccine schedules affect work-
load and scheduling. Time spent following up with phone calls, letters, etc. to hesitant
parents. Time spent trying to contact and offer immunization to those not immunized
when doing a vaccine preventable disease follow-up. (Vaccine provider, Atlantic)
In the second round, 57% of research networks members and 75% of front-line vaccine pro-
viders agreed that vaccine hesitancy is a significant problem in Canada, and 76% of research
networks members and 87% of vaccine providers agreed that it is contributing to sub-optimal
vaccination coverage rates in Canada. The majority of research networks members (66%) and
vaccine providers (78%) agreed that it is crucial to address this issue.
The second questionnaire asked the extent to which participants considered that vaccine
hesitancy focused on specific vaccines. Measles-containing vaccines, newly introduced vac-
cines, influenza vaccines, and human papilloma virus (HPV) vaccines were deemed to contrib-
ute most to vaccine hesitancy by both groups of participants.
Table 2. Participants’ preferred definition of vaccine hesitancy.
Preferred deﬁnition
Deﬁnitions of vaccine hesitancy Research networks
members
Vaccine
Providers
n (%) n (%)
A) SAGE Working Group on Vaccine Hesitancy: Vaccine
hesitancy refers to delay in acceptance or refusal of vaccine
despite availability of vaccination services. Vaccine hesitancy is
complex and context speciﬁc, varying across time, place and
vaccines. It is inﬂuenced by factors such as complacency,
convenience and conﬁdence.
14 (28) 20 (27)
B) Deﬁnition derived from highly cited studies: Vaccine attitudes
can be seen on a continuum, ranging from total acceptance to
complete refusal. Vaccine-hesitant individuals are a
heterogeneous group in the middle of this continuum. Vaccine-
hesitant individuals may refuse some vaccines, but agree to
others; delay vaccines or accept vaccines but are unsure in
doing so.
14 (28) 12 (16)
C) Deﬁnition based on answers to the ﬁrst round: Vaccine
hesitancy refers to reluctance to receive recommended
vaccination because of concerns and doubts about vaccines
that may or may not lead to delayed vaccination or refusal of
one, many or all vaccines.
22 (44) 41 (56)
Two missing answers from research networks members and 9 for vaccine providers.
doi:10.1371/journal.pone.0156118.t002
Vaccine Hesitancy in Canada: A Consultation Study by CIRN
PLOSONE | DOI:10.1371/journal.pone.0156118 June 3, 2016 6 / 16
Causes of vaccine hesitancy in Canada
In the first questionnaire, both panels of participants were asked about the main causes of vac-
cine hesitancy in Canada. The most frequently mentioned causes were misinformation or lack
of knowledge and mistrust and fears around vaccination.
Misinformation about links between diseases, safety and immunizations. Educated, intelli-
gent people who no longer take physician recommendations at face value and wish to
research the recommendations on their own. (Research networks member, Ontario)
People not knowing the risks of disease, not seeing these diseases or burden of disease in
their lifetime. (Vaccine-provider, Atlantic)
Some participants also mentioned that vaccine hesitancy is complex and that there are mul-
tiple causes.
There are many causes and these may differ by individual. Some may have fear, some may
be political “conspiracy theories”, some may be true or perceived prior adverse events, some
lack of knowledge, some beliefs “religious or other”. There is no one issue so there is no one
answer or response.” (Research networks member, Atlantic)
In the second round of data collection, participants were asked to identify what they con-
sider to be the main causes of vaccine hesitancy from a list of causes generated from responses
to the first questionnaire (mean scores on the 10-point Likert scale are shown in Table 3). Par-
ticipants were also asked to rank the three main causes of vaccine hesitancy. For both groups of
participants, the diffusion of negative information on vaccination in Internet and social media
Table 3. Causes of vaccine hesitancy in Canada.
Research networks
members
Vaccine providers
n Mean Score* n Mean Score*
Lack of conﬁdence in vaccines’ safety 53† 7.6† 79 8,5
Lack of conﬁdence in vaccines’ effectiveness 79 6,8
Mistrust of the pharmaceutical industry 54 7.9 80 8,3
Mistrust of conventional medicine 54 5.9 80 6,4
Mistrust of the medical establishment 50 5.8 79 6
Diffusion of negative information on vaccination in Internet and social media 54 8.5 79 9,2
Preference for other mode of prevention 53 6.3 80 7,1
Lack of knowledge about vaccination, misinformation 54 8.4 79 8,7
Anti-vaccine movement and anti-vaccine lobby 54 7.7 77 8,3
Complacency 52 8 79 7,7
Lack of convenience 54 5.1 80 3,7
Issues related to vaccination policies and programs 54 5.8 80 5,6
Poor communication on vaccination by public health authorities 54 6 80 5,5
Religious beliefs against vaccination 54 5.1 80 4,5
Fear of needles and fear of pain - - 80 5
*Mean score on the 10-point Likert scale ranging from 1 = unimportant cause to 10 = very important cause
†Research networks members were asked one item: “Lack of conﬁdence in vaccines”.
doi:10.1371/journal.pone.0156118.t003
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followed by lack of knowledge about vaccination received the highest mean ranks. For research
networks members and vaccine provider participants, respectively, mistrust in the pharmaceu-
tical industry and a lack of confidence in vaccine safety, were the third most important cause of
vaccine hesitancy.
Counseling vaccine-hesitant patients
Front-line vaccine providers were asked to answer specific questions regarding how they deal
with vaccine hesitancy in their practice. In the first round of data collection, the majority of
vaccine providers emphasized that they listen, try to understand the concerns of, and educate
vaccine-hesitant patients about vaccines.
Reassure and listen. I answer parents’ questions and I’m honest and open to keep a trusting
relation with parents. (Vaccine provider, Quebec)
Listen to the parent/client first to find out what their hesitancy is. Build a rapport. The reasons
can vary greatly. . .Determine from this contact what the barriers are. . .it maybe misinformation
and then can provide counsel along with written documentation. (Vaccine provider, Prairies)
The majority of vaccine providers (88%, n = 94) did not hesitate to disclose information on
vaccination risks because of patients concerns and doubts. Most vaccine providers considered
that it was their responsibility to ensure that patients understand the risks of both vaccines and
of non-vaccination and that patients need to have all the facts to make an informed decision.
I feel confident in disclosing what the risks are and do so to everyone that I immunize. (Vac-
cine provider, Prairies)
I think it is better to fully inform people of all benefits and potential risks. I believe leaving
out selective information would not only be unethical but could lead to a climate of distrust
of health care providers and feed the irrational fears and beliefs that some people already
have. (Vaccine provider, Atlantic)
In the second round, vaccine providers were asked about their level of agreement with the
best practices in counselling vaccine-hesitant patients. The preferred approaches were to listen
to concerns, to be non-judgemental and to correct misinformation (Table 4).
In the second round, vaccine providers were asked about their level of confidence in dealing
with vaccine-hesitant patients. Sixty-nine percent (69%) said they were comfortable dealing
with vaccine-hesitant patients and 64% felt capable of counselling them. The majority of
Table 4. Vaccine providers’ level of agreement with statements about the best ways to counsel vaccine-hesitant patients.
Disagree Somewhat Agree Agree
(1 to 4) (5 to 7) (8 to 10)
% % %
Listen to the patients’ concerns, show reassurance, act and talk in a non judgmental way (n = 79) 0 4 96
Correct misinformation / provide most accurate information about vaccines (n = 79) 1 11 88
Remind of the beneﬁts of vaccination and point out the risk of not immunizing (n = 79) 1 27 72
Give fact sheets and other resources about vaccination (e.g. websites, books) (n = 79) 4 32 64
Accommodate patients’ requests (e.g. alternative schedule, vaccine refusal) (n = 79) 4 33 63
Provide personal examples (own vaccination / examples of vaccine-preventable diseases in practice) (n = 78) 17 36 47
Refer patient to other providers or schedule another appointment to discuss vaccination concerns (n = 78) 26 33 41
doi:10.1371/journal.pone.0156118.t004
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vaccine providers considered themselves to be well-prepared to provide information about
risks and benefits, but fewer considered themselves well-prepared to discuss their patients’ val-
ues, priorities and goals, or the link between values and vaccination decisions (Table 5).
Finally, vaccine-providers were asked about their level of trust in vaccine research funded
by different research funding sources. Vaccine research funded by the government and by aca-
demic institutions was more highly trusted than industry funded research (Table 6).
Discussion
The aim of this study was to identify the views of Canadian vaccination experts and health pro-
fessionals concerning the definition, scope, causes, and consequences of vaccine hesitancy in
Canada. Our participants defined vaccine hesitancy as an attitude (doubts, concerns) as well as
a behaviour (refusing some / many vaccines, delaying vaccination). Although both definitions
are similar, this definition could be seen as broader than the definition adopted by the SAGE
Working Group on Vaccine Hesitancy, which recognized vaccine hesitancy to be vaccination
behaviour per se (delay in acceptance or refusal of vaccines). While the WHO definition refers
to behavior, it also acknowledges that factors such as complacency, confidence and conve-
nience can lead to vaccine hesitancy and these factors include beliefs, perceptions, attitudes
and knowledge. The explicit recognition that attitudes and beliefs play an important role in
influencing behaviour suggests aspects that could be addressed by public health interventions.
For example, people who are “on the fence” in their attitudes and beliefs are an important
Table 5. Vaccine providers’ perceived preparedness in dealing with vaccine-hesitant patients (n = 79).
Not at all
prepared
Somewhat
Prepared
Very
prepared
(1–2) (3) (4–5)
% % %
How prepared are you to effectively provide information about risks and beneﬁts of vaccination 2 11 87
How prepared are you to effectively discuss patient/family values, priorities and goals. 8 24 68
How prepared are you to effectively help patient/family understand the link between their values,
priorities and goals and vaccinating/not vaccination (e.g., “I understand that it’s important to you to
give your children the best possible chances of being healthy. Here is how that ﬁts with
vaccinating. . .”)
9 21 70
This question was based on a 5-point Likert-scale ranging from “Not at all prepared” to “Very prepared”.
doi:10.1371/journal.pone.0156118.t005
Table 6. Vaccine providers’ level of trust in vaccine research based upon research funding sources (%).
Disagree Somewhat
Agree
Agree
(1 to 4) (5 to 7) (8 to
10)
% % %
I trust ﬁndings when the research is funded by the government (Public Health Agency of Canada, provincial and
territorial governments, etc.) (n = 98)
0 10 90
I trust ﬁndings when the research is funded by the private sector (pharmaceutical industries) (n = 96) 28 46 26
I trust ﬁndings when the research is funded by academic institutions (Canadian Institute of Health Research,
Universities) (n = 96)
1 10 89
I trust ﬁndings when the research is funded by academic institutions in partnership with the private sector
(pharmaceutical industries) (n = 96)
15 35 50
doi:10.1371/journal.pone.0156118.t006
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group for which public health interventions are needed, because they are “at risk” of stopping
vaccinating and may be more open to public health advice than the outright refusers [29, 30].
Our findings indicate that the majority of participants—both vaccine experts and front-line
vaccine providers–have the perception that vaccine rates have been declining and consider vac-
cine hesitancy an important issue to address in Canada. In the absence of a pan-Canadian
immunization registry linked with validated and standardized measures of vaccine hesitancy,
we lack hard evidence to support an increase in the prevalence of vaccine hesitancy and its
impact on vaccine uptake rates. However, a recent Ontarian study looked at trends in medical
and nonmedical immunization exemptions to measles-containing vaccines over a decade. The
authors found that the overall percentage of students with any exemption classification
remained low between 2002/03 to 2012/13 (<2.5%). However, religious or conscientious
exemptions significantly increased during the study period whereas medical exemptions signif-
icantly decreased for both 7- and 17 years old students [31]. Others studies conducted in the
United States have also found hard evidence of an increase in nonmedical exemptions [32–34].
Furthermore, suboptimal vaccine uptake rates in Canada can be explained by barriers to vacci-
nation in terms of ease of access to vaccination services. Indeed, at the population level, identi-
fying, measuring and monitoring the proportion of individuals who are vaccine-hesitant but
who still follow the recommended schedule is not a simple task. If vaccine hesitancy encom-
passes a heterogeneous group of individuals with diverse attitudes and behaviours, as we sug-
gest, then operationalizing this concept will be challenging [35]. The concept of vaccine
hesitancy has been criticized as being an “ambiguous notion with an uncertain theoretical
background” [36]. As pointed out by Peretti-Watel and collaborators, the heterogeneity in the
conceptualization is problematic. Two groups of people—those who are “uncertain but very
interested and committed in vaccination issues are prone to information seeking and long and
balanced decision-making”, and those who have “no definite opinion, little knowledge and lit-
tle interest about vaccination issues and who randomly forget or delay some vaccines”—could
both be considered vaccine-hesitant, while showing very different attitudinal and behavioural
patterns [36]. Indeed, more effort is needed to improve the ability to measure and assess vac-
cine hesitancy at the population level. Because research has mainly focused on the metrics of
vaccine uptake (coverage rates, delays, refusals), the degree to which vaccine hesitancy influ-
ences vaccination behaviours remains an important, though complex, domain for investigation
[13]. There is an urgent need to develop good techniques to identify and monitor patterns of
both “attitudinal” and “behavioural” vaccine hesitancy in individuals and populations, and
over time [37]. The consensus for most questions found in the current study suggests a com-
mon conceptualization and could serve as a basis for the development of such techniques.
Our findings also illustrate common opinions among vaccine experts and stakeholders
regarding the main causes of vaccine hesitancy in Canada. Negative and false information
about vaccination online and in social media was perceived to be the most important cause of
vaccine hesitancy by participants. Indeed, many studies have suggested that the ubiquity of
anti-vaccination content on the Internet contributes to the increase in vaccine hesitancy [9,
38–43]. Most studies that have examined vaccination-related content on websites or social
media platforms have shown that the quality of information is highly variable with a substan-
tial volume of negative and inaccurate information [42, 44–50]. Despite the potential impact of
the Internet on vaccine hesitancy, limited information is available about parental use of online
vaccination information and its influence on their level of vaccine hesitancy and their decision-
making regarding childhood vaccination [39, 51, 52]. Most studies are descriptive, and though
many attribute the increase in vaccine hesitancy to negative vaccination-related content on the
Internet, they offer limited empirical evidence to support these claims [39, 42, 44, 53]. The
emergence of social media as a source of online health information concomitant with
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decreasing trust in vaccination signals a critical need to understand better the role of social
media in vaccine hesitancy. Further, social media role in vaccine hesitancy creates a need to
develop appropriate strategies for online communication; such strategies should aim to provide
vaccine-supportive information, to address misinformation published online, and to corre-
spond to parents’ needs and interests [45]. The perceived link between the sources of vaccine
research (e.g., government versus industry) funding and trust or mistrust in vaccine informa-
tion requires further research, especially in light of our participants’ own concerns regarding
research funded by the industry.
According to participants, misinformation or lack of knowledge about vaccines are other
important causes of vaccine hesitancy. Indeed, lack or inadequate knowledge is frequently
raised by public health professionals who are dealing with vaccine-hesitant populations [54,
55]. Recent educational interventions to correct ‘misinformation’ about vaccines, however,
were largely ineffective to reduce vaccine hesitancy and, even worst, contribute to augment
negative attitudes in the most vaccine-hesitant participants [56, 57]. The “knowledge-deficit”
assumption can lead to labelling parents with vaccination doubts as innumerate, irrational,
emotional, or easily manipulated by anti-vaccination groups. This rationalist approach implies
that decision-making about vaccination can be improved by “correcting” emotional, cognitive
and social distortions or biases affecting judgement and that external influences, such as those
triggered by media, can be offset [54, 58, 59]. Many studies, however, have shown that vaccine
decision-making is complex and that knowledge is only one of the many determinants of vacci-
nation decisions [35, 54, 60]. While vaccine hesitancy exists in all stratums of the population, it
is often associated to highly-educated parents. Studies conducted in different settings have
shown that non-compliant parents appear to be well-informed individuals who have consider-
able interest in health-related issues and actively seek information [61–63].
As our study has shown, most Canadian vaccine providers support listening to the concerns
of vaccine-hesitant patients, reassuring them in a nonjudgmental way, and providing accurate
information on vaccination [64, 65]. This is in contrast with the recent call for a “gloves off”
approach by public health authorities in the midst of the 2015 measles outbreak [66]. Research
shows the majority of patients see health care professionals as the most trusted source of infor-
mation on vaccination [67, 68], and many tools and tips exist to help providers in their discus-
sions with vaccine-hesitant or vaccine-refusing patients [69–72]. While approaches vary, they
share common characteristics, such as the importance of maintaining a trustworthy patient-
provider relationship, as well as tailoring communication to patients’ specific concerns and
doubts. Three studies assessed the effects of partial or full patient decision aids, which are tools
intended to complement discussions with health care professionals and to facilitate informed
and values-congruent decisions. Few have shown measurable results [25, 73–75]. Clearly, our
results showed providers recognized the common characteristics found in these approaches;
however the lack of results from studied approaches indicates more research may be needed to
identify and implement effective ways to support health care providers’ communication with
vaccine-hesitant patients [64, 76].
The data from our study should be interpreted with some caveats. First, by design the results
reported here represent the opinions of only some non-randomly selected key opinion leaders.
The results of this study were not intended to be representative of all vaccination experts,
health professionals and front-line vaccine providers in Canada. Moreover, the voluntary par-
ticipant sample targeting individuals with vaccine expertise or front-line vaccine delivery expe-
rience resulted in selection bias towards individuals with high interest in the topic of vaccine
hesitancy. In addition, studies have shown that front-line vaccine providers may themselves be
vaccine-hesitant, thus unlikely to strongly recommend vaccines [77, 78]. We did not include
specific questions vaccine providers’ own level of vaccine hesitancy and it is probable that
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participants in our study held pro-vaccine attitudes. However, one third of vaccine-providers
who participate in our study felt uncomfortable dealing with vaccine-hesitant patients and
inadequately prepared to counsel them. Further studies will be needed to better understand
vaccine hesitancy among front-line vaccine providers. Moreover, despite having been invited,
no key opinion leaders from the Northern territories participated in the study. Because we
have adapted our questionnaire for the recruitment of vaccine providers, we were not able to
regroup for analysis the responses of vaccine providers of both panels. Despite these caveats,
our study has generated rich findings on the opinions of key stakeholders regarding the scope
and impact of vaccine hesitancy in Canada. Because vaccine hesitancy is a relatively new
research topic, the use of many open-ended questions allowed us to obtain the opinions of par-
ticipants without biasing the responses based on the research team’s assumptions. The fact that
all data were collected anonymously should also have minimized social desirability bias.
To conclude, this study has shown that vaccine hesitancy is a concern for Canadian vaccina-
tion experts and health professionals. In the context of declining trust in science and state insti-
tutions [79, 80] and increasing consumerist orientation to healthcare [81, 82], more and more
people wish to be–and, indeed, are encouraged to be–engaged in health decisions and to feel
empowered to do so [83–87], regardless of whether their sources of information are perceived
by experts as lacking credibility. It is important for health professionals to recognize the impact
of the broader social landscape that “gives shape to ideas and ideals” about health, prevention
and what a good citizen does about vaccination [88].
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